Generics Industry News Search
 |
|
|
|
|
|
|
November 2005 News Archive |
|
|
| |
|
Mylan Laboratories Inc. today reported that the U.S. District Court for the Western District of Pennsylvania has issued an opinion and order denying Pfizer's motion for summary judgment seeking the dismissal of Mylan's inequitable conduct claims in the Amlodipine Besylate patent litigation....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Barr Pharmaceuticals, Inc. today announced that the United States Court of Appeals for the Second Circuit has affirmed the May 2003 dismissal by U.S. District Judge I. Leo Glasser of all of the plaintiffs' claims against Barr and AstraZeneca in the Tamoxifen Citrate antitrust litigation....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories Limited announces that today the U.K. High Court granted Ranbaxy permission to appeal the ruling of 12 October 2005, that its atorvastatin product would infringe Warner Lambert/Pfizer’s European ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Aurobindo Pharma USA Inc, a wholly-owned subsidiary of Aurobindo Pharma Ltd, is close to acquiring the bankrupt US generic drug maker, Able Laboratories Inc, for a consideration of $21.5 million....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Barr Pharmaceuticals, Inc. today confirmed that the Federal Trade Commission (FTC) has filed a lawsuit in Federal Court seeking injunctive relief to nullify the March 2004 agreement between Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc.,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amgen, the world's largest biotechnology company, today announced that it filed a lawsuit in the United States District Court in Boston, Massachusetts against F. Hoffmann-LaRoche Ltd., ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca announced today that it has filed a lawsuit in the United States District Court for the District of New Jersey against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals Industries, Ltd. for willful infringement of AstraZeneca’s substance patent protecting Seroquel....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories Limited announces that a Norwegian court today handed down its decision in Ranbaxy’s case against Pfizer*, involving patents on atorvastatin in Norway. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. District Court in Chicago today granted Abbott's request for a preliminary injunction that will prevent unauthorized generic copies of Abbott's Biaxin XL from Ranbaxy and Andrx. It is expected that a full patent infringement trial will take place in 2006, although no date has been set....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The day after a copy of GlaxoSmithKline Plc's Paxil hit stores in 2003, the company introduced its own cheaper version of the $3 billion-a-year depression drug....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company’s ANDA for Glimepiride Tablets, 1 mg, 2 mg and 4 mg. Shipment of this product will begin immediately....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories Limited announced today that the Company is raising its equity stake in Nihon Pharmaceutical Industry Co., Ltd. (NPI), a Joint Venture between Ranbaxy and Nippon Chemiphar Co. Ltd. (NC),...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories Limited announced today that the U.S. District Court for the District of Northern Illinois has ruled for Ranbaxy on two patents and against Ranbaxy on a single claim of a third patent. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis’ subsidiary Kéri Pharma Generics, in Hungary, acquired 30 September, has launched the cardiovascular product Ramipril tablets, to the Hungarian market. The product is the first one, supplied to Kéri by Actavis, ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
SICOR Pharmaceuticals Sales, Inc. is pleased to announce the introduction and availability of Octreotide Acetate Injection. This product is AP rated to Sandostatin®* Injection....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark Pharmaceuticals SA, a wholly owned Swiss subsidiary of Glenmark Pharmaceuticals Ltd, acquired an Argentine marketing company Servycal S. A. [Servycal] for an undisclosed consideration. This 100% all-cash acquisition, f...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The spectre of early generic competition against Biovail Corp.'s flagship anti-depressant drug unleashed a wave of frenzied selling by investors yesterday, driving the stock price down more than 10 per cent....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Hi-Tech Pharmacal Co., Inc. announced today that the US Food and Drug Administration (FDA) has granted tentative approval to the Company's Abbreviated New Drug Application (ANDA) for Ofloxacin otic solution, 0.3%....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Bentley Pharmaceuticals, Inc., a technology-based specialty pharmaceutical and drug delivery company with a growing branded and generic product line in Europe today announced that its newly formed Irish subsidiary, Bentley Pharmaceuticals Ireland Limited ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Par Pharmaceutical Companies, Inc. today announced that its wholly-owned subsidiary, Kali Laboratories, Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ondansetron hydrochloride ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca announced today that it has filed a lawsuit in the United States District Court for the District of New Jersey against Ranbaxy Laboratories for willful infringement of AstraZeneca’s patents protecting NEXIUM® (esomeprazole magnesium)....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer said today that the Court of Appeals for the Federal Circuit has affirmed a lower court decision imposing a preliminary injunction against sales of a generic quinapril product manufactured by Ranbaxy Pharmaceuticals Inc. and marketed by Teva Pharmaceuticals ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Australia's biggest generic manufacturer confirmed its challenge to Lundbeck's patent in a one-line statement following a hearing in the Federal Court on 18 November but refused to say more about the case. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. Patent and Trademark Office (USPTO) issued a ruling against one of several patents that Pfizer holds on Lipitor (atorvastatin), its top-selling cholesterol drug. In the reexamination proceeding initiated last year by the Public Patent Foundation (PUBPAT), the USPTO rejected all 44 of the claims of U.S. patent 5,969,156 when it ruled that Pfizer's arguments for securing the patent in 1999 were invalid....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Astellas Pharma Inc. today announced that Astellas filed a patent infringement lawsuit on November 29 with the Tokyo District Court against Toyo Pharmar Co., Ltd. and ASKA Pharmaceutical Co., Ltd. demanding that Toyo Pharmar and ASKA Pharmaceutical stop infringing Astellas' patent rights on its modified release formulation of tamsulosin hydrochloride (brand name: Harnal 0.1 mg/0.2 mg Capsules)....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
American Pharmaceutical Partners (APP), today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for the combination drug Ampicillin and Sulbactam for Injection,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company’s ANDA for Zaleplon Capsules, 5 mg and 10 mg....
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
